Stocktoria
NUTRA PHARMA CORP NPHC
OTC · stock · Medicinal Chemicals & Botanical Products · website · IPO 2001-10-09
NUTRA PHARMA CORP financials (annual, from 10-K)
Bars are annual figures from 2016 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $257,612 | $246,309 | $205,564 | $145,800 | $97,735 | $51,897 | $104,393 | $130,596 | $120,979 | $168,356 |
| Gross profit | $196,628 | $247,323 | $396,455 | $249,022 | $8,467 | $14,916 | $34,715 | $14,062 | $94,076 | -$54,648 |
| SG&A expense | — | $1.1M | $1.2M | $2.1M | $1.9M | $1.1M | $1.2M | $1.4M | $1.5M | $2.0M |
| Operating income | -$1.5M | -$878,421 | -$886,979 | -$1.9M | -$2.0M | -$924,947 | -$1.2M | -$1.9M | -$1.4M | -$2.0M |
| Interest expense | $22,870 | $21,237 | $18,815 | $17,141 | $18,246 | — | — | $574,334 | $343,194 | $293,785 |
| Net income | -$2.0M | -$1.3M | -$1.4M | $8.2M | -$13.1M | -$769,184 | -$6.6M | -$3.9M | -$4.0M | -$3.4M |
| EPS (diluted) | $0.00 | $0.00 | $0.00 | $0.00 | $-0.00 | — | — | — | — | — |
| Operating cash flow | -$1.2M | -$423,959 | -$550,036 | -$762,432 | -$1.7M | -$878,086 | -$743,659 | -$999,949 | -$1.1M | -$1.4M |
| Free cash flow | -$1.2M | — | — | -$820,425 | -$1.8M | -$883,991 | — | — | -$1.1M | -$1.4M |
| Cash & equivalents | $12,181 | $36,447 | $0 | $0 | — | — | — | — | — | — |
| Inventory | $19,535 | $17,696 | $19,544 | $23,866 | $31,289 | $5,271 | $8,177 | $35,302 | $20,142 | $25,562 |
| Total assets | $584,558 | $599,495 | $640,397 | $754,913 | $780,022 | $301,786 | $339,832 | $141,417 | $389,570 | $214,257 |
| Total liabilities | $17.4M | $15.4M | $14.4M | $13.1M | $21.7M | $11.8M | $12.0M | $6.1M | $5.8M | $4.7M |
| Shareholders' equity | -$16.8M | -$14.8M | -$13.8M | -$12.4M | -$20.9M | -$11.5M | -$11.7M | -$5.9M | -$5.4M | -$4.5M |
Growth · year-over-year · Revenue CAGR 4.8%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | +4.6% | +19.8% | +41.0% | +49.2% | +88.3% | -50.3% | -20.1% | +7.9% | -28.1% | -42.2% |
| Net income growth | — | — | -117.0% | — | — | — | — | — | — | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Source: SEC EDGAR filings · CIK 0001119643 · US · as of 2025-12-31. facts plus Stocktoria's own computed scores — not investment advice.